Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-016429

EVP, Preclinical Development acquired 155,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Holsinger Leslie EVP, Preclinical Development 2022-03-03 Grant or award +155,500 159,000 D
Loading xslF345X03/doc4.xml…